Piramal Pharma Ltd
₹237.76
+4.07 (1.74%)
Sat, 07 Nov 2026, 07:36 pm
Piramal Pharma News
Piramal Pharma to host investor meets in Nov
Piramal Pharma Limited will hold institutional investor meetings on November 17 and 18, 2026, in Mumbai, arranged by Avendus Spark and JM Financial.
30 Oct 2026
companies
Piramal Pharma Q2FY27 Results
Piramal Pharma Ltd reported a consolidated net profit of ₹5.03 crore in Q2FY27, turning profitable from a loss last year. Revenue rose 28% YoY to ₹2,617 crore.
27 Oct 2026
companies
Piramal Pharma to host Q2FY27 earnings call on Oct 28
Piramal Pharma Limited will conduct an investor conference call on October 28, 2026, to discuss its Q2 and H1 FY2027 financial results. The session begins at 10:00 am IST.
16 Oct 2026
companies
Piramal Pharma's Bayer sales deal ends December 31, 2026
Piramal Pharma's sales agreement with Bayer Pharmaceuticals will not be renewed and is set to expire on December 31, 2026.
01 Oct 2026
companies
Piramal Pharma gets ₹4.06 Cr GST demand
Piramal Pharma received a GST demand of ₹4.06 crore plus equivalent penalty for FY21-FY23. The company intends to appeal, citing a meritorious case.
29 Sept 2026
companies
Market Current News
Dhanteras gold and silver sales volume seen up 20-30%
Gold and silver sales volumes on Dhanteras are expected to rise 20-30%, driven by a significant drop in precious metal prices, with silver demand leading the increase.
06 Nov 2026
commodities
CONTINENTAL CONTROLS LTD.
Continental Controls rights issue oversubscribed
Continental Controls Limited completed its rights issue of 1.96 crore shares at ₹10 each. The issue was oversubscribed 112.75% and shares list on BSE on November 5, 2026.
05 Nov 2026
ipo
Jivial Industries Limited
Jivial Industries changes IPO machinery vendors
Jivial Industries Ltd approved partial vendor changes for three machinery sets in its IPO project. Costs and timelines remain unchanged despite the switch.
05 Nov 2026
ipo
Antala IPO Day 6: Subscribed 6.43x
Antala Industries IPO sees strong QIB demand at 66.72x on final day. Total subscription reaches 6.43x as Retail and NII interest picks up.
05 Nov 2026
ipo
IGL Spirits lists on BSE and NSE post-demerger
IGL Spirits Limited listed on BSE and NSE on November 4, 2026. The demerged entity reported FY26 revenue of ₹2,801 crore and EBITDA of ₹492 crore.
04 Nov 2026
ipo